A CDC health advisory says published case reports show roughly 40% mortality from arboviral brain infections in patients taking anti-CD20 drugs.
CDC Advisory Reports About 40% Mortality in Published Arbovirus Brain Infections Among Patients on B Cell Depleting Drugs
by | Aug 13, 2026 | Uncategorized | 0 comments

Recent Comments